Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia

Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation

(2010) Massimo Collino et al.   BRITISH JOURNAL OF PHARMACOLOGY

Insulin-resistance and benign prostatic hyperplasia: The connection

(2010) Ajit Vikram et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor γ and thiazolidinedione oral antidiabetic drugs

(2009) S Schinner et al.   BRITISH JOURNAL OF PHARMACOLOGY

Combining a dipeptidyl peptidase-4 inhibitor, alogliptin, with pioglitazone improves glycaemic control, lipid profiles and β-cell function in db/db mice

(2009) Y Moritoh et al.   BRITISH JOURNAL OF PHARMACOLOGY

A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia

(2009) Paloma Alonso-Magdalena et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dietary fatty acid quality affects AR and PPARγ levels and prostate growth

(2009) Esdras L.O. Escobar et al.   PROSTATE

Increased cell proliferation and contractility of prostate in insulin resistant rats: Linking hyperinsulinemia with benign prostate hyperplasia

(2009) A. Vikram et al.   PROSTATE

Pioglitazone opposes neurogenic vascular dysfunction associated with chronic hyperinsulinaemia

(2008) S Takatori et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pleiotropic effects of thiazolidinediones

(2008) CV Rizos et al.   EXPERT OPINION ON PHARMACOTHERAPY

Thiazolidinediones: effects on insulin resistance and the cardiovascular system

(2007) C E Quinn et al.   BRITISH JOURNAL OF PHARMACOLOGY

Intervention of d-glucose ameliorates the toxicity of streptozotocin in accessory sex organs of rat

(2007) A. Vikram et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY